Overdiagnosis of clostridium difficile infection in the molecular test era

JAMA Internal Medicine

Volumn 175, Issue 11, 2015, Pages 1792-1801

  Polage, Christopher R ^a   Gyorke, Clare E ^a   Kennedy, Michael A ^a   Leslie, Jhansi L ^a   Chin, David L ^b   Wang, Susan ^b   Nguyen, Hien H ^c   Huang, Bin ^d   Tang, Yi Wei ^a   Lee, Lenora W ^e   Kim, Kyoungmi ^a   Taylor, Sandra ^f   Romano, Patrick S ^a   Panacek, Edward A ^g   Goodell, Parker B ^a   Solnick, Jay V ^a   Cohen, Stuart H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Yolo Co Department of Public Health   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^g WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; METRONIDAZOLE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL LOAD; BACTERIUM DETECTION; BACTERIUM EXAMINATION; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; COLITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ERROR; DIARRHEA; DISEASE DURATION; FEMALE; FOOD AND DRUG ADMINISTRATION; HOSPITAL ADMISSION; HUMAN; IMMUNOASSAY; INFLAMMATION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEGACOLON; MOLECULAR DIAGNOSIS; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TOXIN ANALYSIS; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; HEALTH SERVICE; HOSPITALIZATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; PREVENTION AND CONTROL; STATISTICS AND NUMERICAL DATA; UNITED STATES; UTILIZATION;

AGED; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COHORT STUDIES; CROSS INFECTION; FEMALE; HOSPITALIZATION; HUMANS; MALE; MEDICAL OVERUSE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; UNITED STATES;

EID: 84946147732     PISSN: 21686106     EISSN: 21686114     Source Type: Journal    
DOI: 10.1001/jamainternmed.2015.4114     Document Type: Article

References (49)

1. Magill SS, Edwards JR, BambergW, et al; Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team. Multistate point-prevalence survey of health care-Associated infections. N Engl J Med. 2014;370(13):1198-1208.
2. Lucado J, Gould C, Elixhauser A. Clostridium difficile Infections (CDI) in Hospital Stays, 2009: Statistical Brief #124. Rockville, MD: Agency for Health Care Policy and Research; 2006-2012. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs.
3. RupnikM, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat RevMicrobiol. 2009;7(7):526-536.
4. McDonald LC, Lessa F, Sievert D, et al; Centers for Disease Control and Prevention (CDC). Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep. 2012;61(9):157-162.
5. ZilberbergMD, Shorr AF, Kollef MH. Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis. 2008;14(6):929-931.
6. Kang J, Sickbert-Bennett EE, Brown VM, Weber DJ, RutalaWA. Changes in the incidence of health care-Associated pathogens at a university hospital from 2005 to 2011. Am J Infect Control. 2014;42(7): 770-775.
7. Dubberke ER, Olsen MA. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis. 2012;55(suppl 2):S88-S92.
8. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353(23):2433-2441.
9. Pin J, Valiquette L, AlaryME, et al. Clostridium difficile-Associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ. 2004;171(5):466-472.
10. Burnham CA, Carroll KC. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev. 2013;26(3):604-630.
11. Longtin Y, Trottier S, Brochu G, et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis. 2013;56(1):67-73.
12. Moehring RW, Lofgren ET, Anderson DJ. Impact of change to molecular testing for Clostridium difficile infection on healthcare facility-Associated incidence rates. Infect Control Hosp Epidemiol. 2013;34(10):1055-1061.
13. Fong KS, Fatica C, Hall G, et al. Impact of PCR testing for Clostridium difficile on incident rates and potential on public reporting: is the playing field level? Infect Control Hosp Epidemiol. 2011;32(9): 932-933.
14. Koo HL, Van JN, Zhao M, et al. Real-time polymerase chain reaction detection of asymptomatic Clostridium difficile colonization and rising C. difficile-Associated disease rates. Infect Control Hosp Epidemiol. 2014;35(6):667-673.
15. Gould CV, Edwards JR, Cohen J, et al; Clostridium difficile Infection Surveillance Investigators, Centers for Disease Control and Prevention. Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection. Clin Infect Dis. 2013;57 (9):1304-1307.
16. Bartlett JG, Taylor NS, Chang T, Dzink J. Clinical and laboratory observations in Clostridium difficile colitis. Am J Clin Nutr. 1980;33(11)(suppl):2521-2526.
17. Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J Jr. Clostridium difficile-Associated diarrhea and colitis. Infect Control Hosp Epidemiol. 1995;16(8):459-477.
18. Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis. 2008;46(suppl 1):S12-S18.
19. Wilcox MH, Planche T, Fang FC, Gilligan P. What is the current role of algorithmic approaches for diagnosis of Clostridium difficile infection? J Clin Microbiol. 2010;48(12):4347-4353.
20. Dubberke ER, Han Z, Bobo L, et al. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J Clin Microbiol. 2011;49(8):2887-2893.
21. Planche TD, Davies KA, Coen PG, et al. Differences in outcome according to Clostridium difficile testingmethod: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis. 2013;13(11):936-945.
22. Kyne L, WarnyM, Qamar A, Kelly CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med. 2000;342(6):390-397.
23. Samore MH, DeGirolami PC, Tlucko A, Lichtenberg DA, Melvin ZA, Karchmer AW. Clostridium difficile colonization and diarrhea at a tertiary care hospital. Clin Infect Dis. 1994;18(2):181-187.
24. Leekha S, Aronhalt KC, Sloan LM, Patel R, Orenstein R. Asymptomatic Clostridium difficile colonization in a tertiary care hospital: admission prevalence and risk factors. AmJ Infect Control. 2013;41(5):390-393.
25. Alasmari F, Seiler SM, Hink T, Burnham CA, Dubberke ER. Prevalence and risk factors for asymptomatic Clostridium difficile carriage. Clin Infect Dis. 2014;59(2):216-222.
26. Polage CR, Solnick JV, Cohen SH. Nosocomial diarrhea: evaluation and treatment of causes other than Clostridium difficile. Clin Infect Dis. 2012;55(7): 982-989.
27. Brecher SM, Novak-Weekley SM, Nagy E. Laboratory diagnosis of Clostridium difficile infections: there is light at the end of the colon. Clin Infect Dis. 2013;57(8):1175-1181.
28. Ryder AB, Huang Y, Li H, et al. Assessment of Clostridium difficile infections by quantitative detection of tcdB toxin by use of a real-time cell analysis system. J Clin Microbiol. 2010;48(11):4129-4134.
29. Leslie JL, Cohen SH, Solnick JV, Polage CR. Role of fecal Clostridium difficile load in discrepancies between toxin tests and PCR: is quantitation the next step in C. difficile testing? Eur J Clin Microbiol Infect Dis. 2012;31(12):3295-3299.
30. Huang B, Jin D, Zhang J, et al. Real-time cellular analysis coupled with a specimen enrichment accurately detects and quantifies Clostridium difficile toxins in stool. J Clin Microbiol. 2014;52(4):1105-1111.
31. Viscidi R, Laughon BE, Yolken R, et al. Serum antibody response to toxins A and B of Clostridium difficile. J Infect Dis. 1983;148(1):93-100.
32. Cardona DM, Rand KH. Evaluation of repeat Clostridium difficile enzyme immunoassay testing. J Clin Microbiol. 2008;46(11):3686-3689.
33. Borek AP, Aird DZ, Carroll KC. Frequency of sample submission for optimal utilization of the cell culture cytotoxicity assay for detection of Clostridium difficile toxin. J Clin Microbiol. 2005;43 (6):2994-2995.
34. Khanna S, Pardi DS, Rosenblatt JE, Patel R, Kammer PP, Baddour LM. An evaluation of repeat stool testing for Clostridium difficile infection by polymerase chain reaction. J Clin Gastroenterol. 2012;46(10):846-849.
35. Deshpande A, Pasupuleti V, Patel P, et al. Repeat stool testing to diagnose Clostridium difficile infection using enzyme immunoassay does not increase diagnostic yield. Clin Gastroenterol Hepatol. 2011;9(8):665-669.e1. doi:10.1016/j.cgh.2011 .04.030.
36. Polage CR, Chin DL, Leslie JL, Tang J, Cohen SH, Solnick JV. Outcomes in patients tested for Clostridium difficile toxins. Diagn Microbiol Infect Dis. 2012;74(4):369-373.
37. Gerding DN, Olson MM, Peterson LR, et al. Clostridium difficile-Associated diarrhea and colitis in adults: a prospective case-controlled epidemiologic study. Arch Intern Med. 1986;146(1):95-100.
38. Walker AS, Eyre DW, Wyllie DH, et al; Infections in Oxfordshire Research Database. Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection. Clin Infect Dis. 2013;56(11):1589-1600.
39. de Jong E, de Jong AS, Bartels CJ, van der Rijt-van den Biggelaar C, MelchersWJ, Sturm PD. Clinical and laboratory evaluation of a real-time PCR for Clostridium difficile toxin A and B genes. Eur J Clin Microbiol Infect Dis. 2012;31(9):2219-2225.
40. Beaulieu C, Dionne LL, Julien AS, Longtin Y. Clinical characteristics and outcome of patients with Clostridium difficile infection diagnosed by PCR versus a three-step algorithm. Clin Microbiol Infect. 2014;20(10):1067-1073.
41. Baker I, Leeming JP, Reynolds R, Ibrahim I, Darley E. Clinical relevance of a positive molecular test in the diagnosis of Clostridium difficile infection. J Hosp Infect. 2013;84(4):311-315.
42. Kaltsas A, Simon M, Unruh LH, et al. Clinical and laboratory characteristics of Clostridium difficile infection in patients with discordant diagnostic test results. J Clin Microbiol. 2012;50(4):1303-1307.
43. Guerrero DM, Chou C, Jury LA, Nerandzic MM, Cadnum JC, Donskey CJ. Clinical and infection control implications of Clostridium difficile infection with negative enzyme immunoassay for toxin. Clin Infect Dis. 2011;53(3):287-290.
44. Humphries RM, Uslan DZ, Rubin Z. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity. J Clin Microbiol. 2013;51(3):869-873.
45. Berry N, Sewell B, Jafri S, et al. Real-time polymerase chain reaction correlates well with clinical diagnosis of Clostridium difficile infection. J Hosp Infect. 2014;87(2):109-114.
46. Lashner BA, Todorczuk J, Sahm DF, Hanauer SB. Clostridium difficile culture-positive toxin-negative diarrhea. Am J Gastroenterol. 1986; 81(10):940-943.
47. Sydnor ER, Lenhart A, Trollinger B, et al. Antimicrobial prescribing practices in response to different Clostridium difficile diagnostic methodologies. Infect Control Hosp Epidemiol. 2011; 32(11):1133-1136.
48. Davies KA, Longshaw CM, Davis GL, et al. Underdiagnosis of Clostridium difficile across Europe: the European, Multicentre, Prospective, Biannual, Point-Prevalence Study of Clostridium difficile Infection in Hospitalised PatientsWith Diarrhoea (EUCLID). Lancet Infect Dis. 2014;14(12):1208-1219.
49. Department of Health, United Kingdom. Updated guidance on the diagnosis and reporting of Clostridium difficile. https://www.gov.uk/government/publications/updated-guidance-on-The-diagnosis-And-reporting-of-clostridium-difficile. Accessed July 8, 2015.